German officials will discuss a reported U.S. attempt to secure the
rights to any coronavirus vaccine developed by a German pharmaceutical
company in crisis meetings on Monday, the country's interior minister
said, amid concerns that the Trump administration was trying to
monopolize the market.
Publisher: Washington Post | Author: Loveday Morris